727
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Development of a Risk Reduction Intervention to Reduce Bacterial and Viral Infections for Injection Drug Users

, , &
Pages 54-64 | Published online: 27 Sep 2012

REFERENCES

  • Avants, S. K., Margolin, A., Usubiaga, M. H., & Doebrick, C. (2004). Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. Journal of Substance Abuse Treatment, 26, 67–78.
  • Belcher, L., Kalichman, S., Topping, M., Smith, S., Emshoff, J., Norris, F., & Nurss, J. (1998). A randomized trial of a brief HIV risk reduction counseling intervention for women. Journal of Consulting and Clinical Psychology, 66, 856–861.
  • Binswanger, I. A., Kral, A. H., Blumenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000). High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases, 30, 579–581.
  • Booth, R. E., Corsi, K. F., & Mikulich-Gilbertson, S. K. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence, 74, 177–185.
  • Boyce, J. M, & Pittet, D. (2002). Guideline for hand hygiene in health-care settings: Recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. Infection Control and Hospital Epidemiology, 23(12 Suppl.), S3–S40.
  • Bryan, A. D., Fisher, J. D., Fisher, W. A., & Murray, D. M. (2000). Understanding condom use among heroin addicts in methadone maintenance using the information-motivation-behavioral skills model. Substance Use & Misuse, 35, 451–471.
  • Carey, M. P., Braaten, L. S., Maisto, S. A., Gleason, J. R., Forsyth, A. D., Durant, L. E., & Jaworski, B. C. (2000). Using information, motivational enhancement, and skills training to reduce the risk of HIV infection for low-income urban women: A second randomized clinical trial. Health Psychology, 19, 3–11.
  • Chitwood, D., Griffin, D., Comerford, M., Page, J., Trapido, E., Lai, S., & McCoy, C. (1995). Risk factors for HIV-1 seroconversion among injection drug users: A case control study. American Journal of Public Health, 85, 1538–1542.
  • Ciccarone, D., Bamberger, J., Krai, A., Edlin, B., Hobart, C., Moon, A., Murphy, E., Bourgois, P., Harris, H., & Young, D. (2001). Soft tissue infections among injection drug users-San Francisco, California, 1996–2000. Centers for Disease Control Morbidity and Mortality Weekly Report, 50, 381–384.
  • Ciccarone, D., & Bourgois, P. (2003). Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use and Misuse, 38, 2049–2063.
  • Colon, H. M., Finlinson, H. A., Negron, J., Sosa, I., Rios-Olivares, E., & Robles, R. R. (2009). Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico. AIDS and Behavior, 13, 523–531.
  • Compton, W. M., Horton, J. C., Cottler, L. B., Booth, R. E., Leukefeld, C. G., Singer, M., Cunningham-Williams, R., Reich, W., Fortuin Corsi, K., Staton, M., Fink, J. L., Stopka, T. J., & Spitznagel, E. L. (2004). A multistate trial of pharmacy syringe purchase. Journal of Urban Health, 81, 661–670.
  • Copenhaver, M. M., Johnson, B. T., Lee, I. C., Harman, J. J., Carey, M. P., & SHARP Research Team. (2006). Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163–171.
  • Drug Enforcement Agency (DEA). (2003). 2002 Domestic monitor program (DEA-03057). Washington, DC: U.S. Department of Justice.
  • Fisher, J. D., & Fisher, W. A. (1992). Changing AIDS-risk behavior. Psychological Bulletin, 11, 455–474.
  • Fisher, J. D., Fisher, W. A., Bryan, A. D., & Misovich, S. J. (2002). Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychology, 21, 177–186.
  • Fisher, J. D., Fisher, W. A., Misovich, S. J., Kimble, D. L., & Malloy, T. E. (1996). Changing AIDS risk behavior: Effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychology, 15, 114–123.
  • Gordon, R. J., & Lowy, F. D. (2005). Bacterial infections in drug users. New England Journal of Medicine, 353, 1945–1954.
  • Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment, 19, 247–252.
  • Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42–46.
  • Huo, D., & Ouellet, L. J. (2007). Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45, 108–114.
  • Hutin, Y., Hauri, A., Chiarello, L., Catlin, M., Stilwel, B., Ghebrehiwet, T., Garner, J., & Injection Safety Best Practices Developments. (2003). Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bulletin of the World Health Organization, 81, 491–500.
  • Jose, B., Friedman, S. R., Neaigus, A., Curtis, J. P., Grund, J. P., Goldstein, M. F., Ward, T. P., & Des Jarlais, D. C. (1993). Syringe mediated drug-sharing (backloading): A new risk factor for HIV among injecting drug users. AIDS, 7, 1653–1660.
  • Knittel, A. K., Wren, P. A., & Gore, L. (2010). Lessons learned from a peri-urban needle exchange. Harm Reduction Journal, 7, 8.
  • Krueger, R. A., & Casey, M. A. (2000). Focus groups: A practical guide for applied research (3rd ed.). Thousand Oaks, CA: Sage.
  • Lundahl, B. W., Kunz, C., Brownell, C., Tollefson, D., & Burke, B. L. (2010). A meta-analysis of motivational interviewing: Twenty-five years of empirical studies. Research on Social Work Practice, 20, 137–160.
  • Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003). A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology, 22, 223–228.
  • Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S. R. (2010). Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. International Journal of Drug Policy, 21, 179–185.
  • Maxwell, J. C., & Spence, R. T. (2006). An exploratory study of inhalers and injectors who used black tar heroin. Journal of Maintenance in the Addictions, 3(1), 61–82.
  • McLauchlin, J., Mithani, V., Bolton, F. J., Nichols, G. L., Bellis, M. A., Syed, Q., Thomson, R. P. M., & Ashton, J. R. (2002). An investigation into the microflora of heroin. Journal of Medical Microbiology, 51, 1001–1008.
  • Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford Press.
  • Murphy, E. L., DeVita, D., Liu, H., Vittinghoff, E., Leung, P., Ciccarone, D. H., & Edlin, B. R. (2001). Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clinical Infectious Diseases, 33, 35–40.
  • Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., Schechter, M. T., Rekart, M. L., & O'Shaughnessy, M. V. (1997). Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8, 437–445.
  • Phillips, K. T., & Stein, M. D. (2010). Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. The American Journal of Drug and Alcohol Abuse, 36, 92–97.
  • Phillips, K. T., Stein, M. D., Anderson, B. J., & Corsi, K. F. (2012). Skin and needle hygiene intervention for injection drug users: Results from a randomized, controlled Stage I pilot trial. Journal of Substance Abuse Treatment, doi:10.1016/j. jsat.2012.01.003.
  • Public Health Department of Seattle & King County. (2002). All about abscesses. Retrieved September 4, 2012, from http://www.kingcounty.gov/healthservices/health/communicable/hiv/HarmReduction.
  • Robles, R. R., Reyes, J. C., Colón, H. M., Sahai, H., Marrero, C. A., Matos, T. D., Calderón, J. M., & Shepard, E. W. (2004). Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study. Journal of Substance Abuse Treatment, 27, 145–152.
  • Rosenberg, H., & Phillips, K. T. (2003). Acceptance and availability of innovative harm-reduction therapies for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors, 17, 203–210.
  • Rotheram-Borus, M. J., Rhodes, F., Desmond, K., & Weiss, R. E. (2010). Reducing HIV risks among active injection drug and crack users: The safety counts program. AIDS and Behavior, 14, 658–668.
  • Rounsaville, B. J., Carroll, K. M., & Onken, L. S. (2001). A stage model of behavioral therapies research: Getting started and moving on from stage I. Clinical Psychology: Science and Practice, 8, 133–142.
  • Royer, M., Fuller, B. E., Ober, A., & Booth, R. E. (2004). HIV and HCV counseling and education (C&E) intervention training manual, version 3.0. (NIH Publication No. 93–3580). Bethesda, MD: National Institute on Drug Abuse.
  • Stein, M. D., & Sobota, M. (2001). Injection drug users: Hospital care and charges. Drug and Alcohol Dependence, 64, 117–120.
  • Strathdee, S. A., Case, P., Lozada, R., Mantsios, A. R., Alvelais, J., Pu, M., Brouwer, K. C., Miller, C. L., & Patterson, T. L. (2008). The color of meth: Is it related to adverse health outcomes? An exploratory study in Tijuana, Mexico. American Journal of Addiction, 17, 111–115.
  • Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., & Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine, 161, 1281–1288.
  • Tuazon, C. U., Hill, R., & Sheagren, J. N. (1974). Microbiologic study of street heroin and injection paraphernalia. Journal of Infectious Disease, 129, 327–329.
  • Tucker, T., Fry, C. L., Lintzeris, N., Baldwin, S., Ritter, A., Donath, S., & Whelan, G. (2004). Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. Addiction, 99, 1157–1166.
  • Varga, L. M., Chitwood, D. D., & Fernandez, I. (2006). Research note: Factors associated with skin cleaning prior to injection among drug users. The Journal of Drug Issues, 36(4), 1015–1030.
  • Vlahov, D., Sullivan, M., Astemborski, J., & Nelson, K. E. (1992). Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Reports, 107, 595–598.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.